ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Time-Sensitive Antibiotic Adjustments in Gram-Negative Bacteremia: A Survival Perspective.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND This retrospective study was designed to assess risk factors for increased 30-day mortality from bacteremia caused by Escherichia coli or Klebsiella pneumoniae and to calculate the optimal point of time for patients to move from inappropriate empirical antimicrobial therapy to appropriate treatment. MATERIAL AND METHODS This retrospective study analyzed data from 610 patients with a diagnosis of E. coli- and K. pneumoniae-induced bacteremia collected between 2020 and 2023, including population-based information, infection bacteria, comorbidities, and treatment duration. Patients were categorized into 2 groups based on whether they received appropriate empirical antibiotic therapy (AEAT) or inappropriate empirical antibiotic therapy (IEAT). Propensity score-matched (PSM) analysis was performed using 1: 1 nearest neighbor matching. Receiver operating characteristic (ROC) curve analysis determined the time point for patients in the IEAT group to transition to appropriate therapy. RESULTS The study found that 30-day mortality was higher in the IEAT group than in the AEAT group (P=0.043). Multifactorial Cox regression analysis after PSM indicated that Pitt score (P<0.001), age-adjusted Charlson comorbidity index score (P<0.001), and inappropriate treatment days (P=0.018) were independent risk factors for increased 30-day mortality. The area under the ROC curve value was 0.613, and the maximum Youden index corresponded to a time turning point of 8 days. CONCLUSIONS Pitt and aCCI scores and inappropriate treatment days are significant risk factors for increased 30-day mortality in patients with E. coli or K. pneumoniae. Timely transition from inappropriate antibiotic to appropriate antibiotic therapy within 8 days was found to improve survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.